Volver

Abbott Laboratories

Ticker: ABT ISIN: US0028241000
Añadir al portafolio Análisis de cartera en 2min
Stock Large-cap Dividend payer Trading above 200-day average
Capitalización
154,15 MM $
P/E
24,79
Forward P/E
16,53
Profit margin
13,90%
Revenue growth QoQ
7,80%
Div. yield
2,69%
Beta
0,62
116,13 $ -0,46%
Precio a fecha de 2026-08-25 · NYSE

Rendimiento por período

Rendimientos acumulados
1 Month +11,14%
6 Months +2,55%
1 Year -9,71%
5 Years +0,54% p.a.+2,73%
10 Years +12,49% p.a.+224,14%
Since inception +9,55% p.a.+874,83%
Rendimientos por año
YTD -5,59%
2025 +12,87%
2024 +4,82%
2023 +2,26%
2022 -20,68%
2021 +30,53%

Key stats

Market cap
154,15 MM
P/E
24,79
Dividend yield
2,69%
Beta
0,62
52-week range
81.97 - 136.28
50-day MA
90,43
200-day MA
113,85
Section 1

Business overview

Company profile data from fundamentals.

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.

Sector Healthcare
Industry Medical Devices
Country United States
Exchange NYSE
Section 2

Financial quality

Profitability and balance-sheet quality indicators from reported fundamentals.

Profitability

ROE 12,33%
ROA 5,59%
Profit margin 13,90%
Operating margin 13,47%
PEG ratio 1,34
Revenue/share TTM 25,91
Revenue TTM 45,13 MM
EBITDA 11,74 MM
Gross profit TTM 25,50 MM
Beta 0,62

Valuation

Trailing P/E 24,79
Forward P/E 16,53
P/B 3,03
P/S 3,42
EV/EBITDA 15,60
EV/Revenue 4,09

ESG Scores

Total ESG 32,4
Environment 4,0
Social 20,7
Governance 13,2
Section 3

Earnings

Earnings metrics from company highlights and earnings datasets.

EPS estimate (current year) 5,48
Quarterly earnings growth -19,70%
Revenue TTM 45,13 MM
Reported quarters 129
Section 4

Dividends & corporate actions

Dividend and split fields from fundamentals.

Dividend yield 2,69%
Forward annual div. yield 1,75%
Dividend per share 2,4400
Payout ratio 53,70%
Ex-dividend date 2025-07-15
Next dividend date 2026-08-17
Split factor 10000:4798
Last split date 2013-01-02
Section 5

Ownership / analyst view

Institutional ownership and analyst estimate fields when available.

Analyst

Analyst target price 142,48 $
Analyst rating 4.1071

Ownership & short interest

Shares outstanding 1,74 MM
Shares float 1,73 MM
Institutional ownership 80,78%
Insider ownership 54,30%
Short ratio 1,73
Short % of float 1,41%

Details

Instrument metadata and source update timestamps.

Symbol ABT
Name Abbott Laboratories
Asset type STOCK
Exchange NYSE
Currency USD
ISIN US0028241000
Country USA
Code + exchange ABT.NYSE
Last price date 2026-06-17
Fundamentals updated 2026-06-18

La información proporcionada en esta plataforma es solo para fines informativos y no debe considerarse como asesoramiento financiero o de inversión. Insightfolio no ofrece asesoramiento financiero, recomendaciones personalizadas ni orientación sobre la compra, tenencia o venta de activos financieros. Las herramientas y contenidos son únicamente educativos y no están adaptados a las circunstancias, necesidades financieras u objetivos personales.

Insightfolio no asume ninguna responsabilidad por la precisión, integridad o fiabilidad de la información presentada. Es responsabilidad exclusiva de los usuarios verificar la información y tomar decisiones independientes basándose en su propia investigación y consideración. El uso de esta plataforma no reemplaza la consulta con profesionales financieros cualificados.

Invertir implica riesgos. Los usuarios deben ser conscientes de que el valor de las inversiones puede fluctuar y que los rendimientos pasados no son garantía de resultados futuros. Las decisiones de inversión deben basarse en objetivos financieros personales, tolerancia al riesgo y una evaluación independiente de la información relevante.

Insightfolio no respalda ni garantiza la idoneidad de ningún producto financiero, valor o estrategia en particular. Cualquier proyección, pronóstico o escenario hipotético presentado en la plataforma es solo ilustrativo y no constituye una garantía.

Al acceder a los servicios, información o contenido ofrecido por Insightfolio, los usuarios reconocen y aceptan los términos de este aviso legal. Si no estás de acuerdo con estos términos, por favor no uses nuestra plataforma.

Logotipos de instrumentos proporcionados por Elbstream.